MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    OPICAPONE: REAL WORLD EVIDENCE IN TOLEDO´S MOVEMENT DISORDERS UNIT

    JC. Segundo-Rodríguez, N. López-Ariztegui, MI. Morales-Casado, N. García-Alvarado, A. Avila-Fernández, J. Pérez-Matos (Toledo, Spain)

    Objective: We present a prospective observational-real life study about the use in Movement Disorders Unit´s patients, since its commercialization in Spain (June 2017). Background: The…
  • 2019 International Congress

    Vortioxetine treatment of depression in Parkinson’s disease

    M. Russo, C. Carrarini, F. Dono, L. Ferri, M. Di Pietro, M. Onofrj (Chieti, Italy)

    Objective: To assess efficacy and safety of Vortioxetine in Parkinson’s Disease (PD) patients affected by depression and its effects on motor performance. Background: Depression is…
  • 2019 International Congress

    Quercetin Regulates Cadmium Induced Motor Dysfunction in Depletion of Dopamine and its Metabolites at Synapse

    R. Gupta, RK. Shukla, AB. Pant, VK. Khanna (Lucknow, India)

    Objective: The present study has an attempt to understand cadmium induced alteration in dopamine and associated signaling that causes the motor alterations in rats and…
  • 2019 International Congress

    Early onset parkinsonism and optic atrophy due to SLC25A46 mutations

    G. Bitetto, MC. Malaguti, E. Monfrini, A. Di Fonzo (Milan, Italy)

    Objective: To define the genetic background of a case affected by parkinsonism with optic atrophy. Background: Mutations in SLC25A46 have been recently described as causative…
  • 2019 International Congress

    Mechanism-based classification in PD cohorts

    B. Labrador, F. Danjou, S. Bekadar, FX. Lejeune, H. Froehlich, M. Hofmann-Apitius, JC. Corvol (Paris, France)

    Objective: To stratify Parkinson’s disease (PD) patients based on key molecular mechanisms by using a genomic-based approach. Background: PD is a complex neurodegenerative disease involving…
  • 2019 International Congress

    Clinicopathologic Characterization and Abnormal Autophagy of HDLS

    W. Tian, L. Cao, S. Chen (Shanghai, China)

    Objective: We aimed to investigate clinical and pathological characteristics in hereditary diffuse leukoencephalopathy with spheroids (HDLS) patients and explore the potential impact of colony-stimulating factor…
  • 2019 International Congress

    Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation

    Z. Voysey, L. Azzopardi, B. Fiddes, S. Bradberry (Romford, United Kingdom)

    Objective: To evaluate the efficacy of calcium disodium edetate (CaNa2EDTA) chelation as a treatment for acquired hepatocerebral degeneration. Background: Acquired hepatocerebral degeneration is a rare…
  • 2019 International Congress

    Dyadic analysis of the Parkinson’s disease impact on the patient-spouse couple

    E. Constant, E. Brugallé, E. Wawrziczny, B. Flinois, K. Dujardin, P. Antoine (Villeneuve D'Ascq, France)

    Objective: The present research aims to understand the dyadic functioning of couples faced with Parkinson’s disease (PD) considering disease progression. Background: PD has detrimental effects…
  • 2019 International Congress

    The Impact of Parkinson’s Disease to Quality of Life

    R. Pinzon, RDL. Sanyasi (Yogyakarta, Indonesia)

    Objective: The objective of this study is to identify the quality of life in patients with Parkinson's Disease Background: Parkinson’s disease (PD) is a neurodegenerative…
  • 2019 International Congress

    Evaluation and Intervention of Aquatic Physiotherapy in People with Parkinson’s Disease: Repercussions on Balance

    V. Israel, D. Iucksch, J. Siega, A. Silva, B. Yamaguchi, M. Ferreira (Curitiba, Brazil)

    Objective: To analyze the effects of aquatic physiotherapy (AF) on the static and dynamic body balance of patients with Parkinson's disease (PD). Background: PD changes…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley